$QTTB 3 SEC Filings

Filed On	Filing
08 Jun 2026	Form 3: Atlas Venture Opportunity Fund Ill, L.p., See Remarks and 2 others Holds 625,000 shares of Common Stock
27 Mar 2024	Form 3: Violette Shelia M., Chief Scientific Officer Holds 36,277 shares of Common Stock
27 Mar 2024	Form 3: Grayzel David S., Director Holds 864,261 shares of Common Stock
27 Mar 2024	Form 3: Manke Isaac, Director No securities owned
27 Mar 2024	Form 3: Xu Diyong, Director Holds 2,252,987 shares of Common Stock
27 Mar 2024	Form 3: Morrison Jodie Pope, Director
27 Mar 2024	Form 3: Laporte Kathleen, Director Holds 5,431 shares of Common Stock
27 Mar 2024	Form 3: Campagna Jason, Chief Medical Officer
27 Mar 2024	Form 3: Kalowski Lee, CFO and President
27 Mar 2024	Form 3: Orbimed Advisors Llc, Director and 1 other Holds 2,252,987 shares of Common Stock
27 Mar 2024	Form 3: Iwicki Mark T, Director
27 Mar 2024	Form 3: Atlas Venture Fund X, L.p., 10% owner and 8 others Holds 864,261 shares of Common Stock
27 Mar 2024	Form 3: Lundberg Sven Ante, Director Holds 1,200 shares of Common Stock
17 Nov 2023	Form 3: Michaud Charles Jr, See Remarks Holds 2,112 shares of Common Stock
16 Mar 2023	Form 3: Jordan Julie, Chief Medical Officer Holds 2,519 shares of Common Stock
11 Mar 2022	Form 3: Alloway Paul, See Remarks Holds 10,226 shares of Common Stock
11 Mar 2022	Form 3: Blum Michael Lee, Chief Commercial Officer Holds 6,780 shares of Common Stock
21 Jul 2020	Form 3: Poulton Jeffrey V., Director No securities owned
03 Dec 2019	Form 3: Cohn Gabriel, Chief Medical Officer No securities owned
15 Jul 2019	Form 3: Reicin Alise, Director No securities owned

Comments